Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (141-150 of 353) with videos related to

Pageof 36
Sort By:
The American Journal of Cardiology|March 1, 2022
Relationship between Index Myocardial Infarction Type and Early Recurrent Myocardial InfarctionRaunak Mohan Nair, Michael Johnson, Kathleen Kravitz, et al.
American Journal of Cardiovascular Disease|March 8, 2013
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromesDharam J Kumbhani, Brian J Wells, A Michael Lincoff, et al.
Circulation|April 6, 2024
Impact of Bempedoic Acid on Cardiovascular Outcomes by SexLeslie Cho, Jorge Plutzky, Danielle Brennan, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Impact of drug-eluting versus bare-metal stents on mortality in patients with anemiaMehdi H Shishehbor, Steven J Filby, Adnan K Chhatriwalla, et al.
Journal of the American Heart Association|April 17, 2023
Impact of a Comprehensive ST-Segment-Elevation Myocardial Infarction Protocol on Key Process Metrics in Black AmericansRaunak M Nair, Anirudh Kumar, Chetan P Huded, et al.
The American Journal of Cardiology|May 15, 2002
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiencyAllen Jeremias, Deepak L Bhatt, Derek P Chew, et al.
Journal of the American Heart Association|March 23, 2019
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-AnalysisSafi U Khan, Hammad Rahman, Victor Okunrintemi, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
The American Journal of Cardiology|July 13, 2004
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortalityVivek Rajagopal, Hitinder S Gurm, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|November 3, 2004
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trialDavid J Cohen, A Michael Lincoff, Tara A Lavelle, et al.
Pageof 36

Showing results (141-150 of 353) with videos related to

Sort By:
Pageof 36
The American Journal of Cardiology|March 1, 2022
Relationship between Index Myocardial Infarction Type and Early Recurrent Myocardial InfarctionRaunak Mohan Nair, Michael Johnson, Kathleen Kravitz, et al.
American Journal of Cardiovascular Disease|March 8, 2013
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromesDharam J Kumbhani, Brian J Wells, A Michael Lincoff, et al.
Circulation|April 6, 2024
Impact of Bempedoic Acid on Cardiovascular Outcomes by SexLeslie Cho, Jorge Plutzky, Danielle Brennan, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Impact of drug-eluting versus bare-metal stents on mortality in patients with anemiaMehdi H Shishehbor, Steven J Filby, Adnan K Chhatriwalla, et al.
Journal of the American Heart Association|April 17, 2023
Impact of a Comprehensive ST-Segment-Elevation Myocardial Infarction Protocol on Key Process Metrics in Black AmericansRaunak M Nair, Anirudh Kumar, Chetan P Huded, et al.
The American Journal of Cardiology|May 15, 2002
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiencyAllen Jeremias, Deepak L Bhatt, Derek P Chew, et al.
Journal of the American Heart Association|March 23, 2019
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-AnalysisSafi U Khan, Hammad Rahman, Victor Okunrintemi, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
The American Journal of Cardiology|July 13, 2004
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortalityVivek Rajagopal, Hitinder S Gurm, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|November 3, 2004
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trialDavid J Cohen, A Michael Lincoff, Tara A Lavelle, et al.
Pageof 36